Filippo Acconcia

Filippo Acconcia

Sep 21, 2017

Group 6 Copy 34
0
    Please wait...

    About This Project

    70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Assessing Guadalupe Fur Seal Health and Ecology

    A multidisciplinary team of researchers will assess the health of Guadalupe fur seal pups and adults by...

    Campaign Ended